Journal of International Oncology››2012,Vol. 39››Issue (5): 377-380.

Previous ArticlesNext Articles

Basal-like breast cancer

LI Sheng-lan, ZHANG Qing-yuan

  1. Department of Internal Medicine, Third Affiliated Hospital of Harbin Medicical University, Harbin 150080, China
  • Online:2012-05-08Published:2012-05-02
  • Contact:ZHANG Qing-yuan, E-mail: zhma19650210@163.com E-mail:zhma19650210@163.com

Abstract:Basal-like breast cancer (BLBC) is a basal cell phenotype and associated with different levels of expression in basal cell keratin and (or) myoepithelial markers in breast cancer, which has a unique genetic phenotype and morphological characteristics. BLBC is prevalent in young woman, and it is easy to relapse and metastasis. Additionally, most BLBC has expression loss of estrogen receptor and progesterone receptor and human epidermal growth factor receptor 2, which limits the targeted therapeutic options for these predominantly triple-negative breast cancers.

Key words:Breast neoplasms,Molecular pathology,Therapy